Skip to content

Drug interactions

Nateglinide + Valproic acid

Severity: Minor

Nateglinide and Valproic acid: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Valproic acid can inhibit CYP2C9 weakly, and nateglinide is partly cleared by CYP2C9. Nateglinide exposure could rise slightly, increasing the risk of hypoglycemia, but the effect is expected to be small.

What this interaction means in plain words

Nateglinide and Valproic acid have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Nateglinide belongs to Endocrine; Valproic acid belongs to Central Nervous System.

Evidence level: Low

Why it happens

Weak inhibition of CYP2C9-mediated nateglinide metabolism.

What to do

Monitor blood glucose when starting or stopping valproate and adjust nateglinide if hypoglycemia occurs.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Nateglinide and Valproic acid, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Nateglinide with Valproic acid?

MediHelp rates the interaction as minor. Nateglinide and Valproic acid have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Valproic acid can inhibit CYP2C9 weakly, and nateglinide is partly cleared by CYP2C9. Nateglinide exposure could rise slightly, increasing the risk of hypoglycemia, but the effect is expected to be small.

How serious is the interaction between Nateglinide and Valproic acid?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose when starting or stopping valproate and adjust nateglinide if hypoglycemia occurs.

What other medicines interact with Valproic acid?

MediHelp also lists interactions of Valproic acid with, for example, Ertapenem, Imipenem / cilastatin / relebactam, Imipenem / cilastatin. The full list is on the Valproic acid page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in